Poking CD40 for cancer therapy, another example of the Goldilocks effect

Cancer Biol Ther. 2010 Nov 15;10(10):994-6. doi: 10.4161/cbt.10.10.13976. Epub 2010 Nov 15.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / pharmacokinetics
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • CD40 Antigens / agonists*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / immunology*
  • Remission Induction

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • CD40 Antigens
  • selicrelumab